Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
2 Relatively Safe Dividend Stocks You Won't Regret Owning
10:07am, Tuesday, 28'th Mar 2023
Companies that hike their dividends over and over tend to be financially healthy. AbbVie's good track record with commercializing medicines is likely to continue.
This Is the Best Dividend ETF You Can Buy
08:13am, Tuesday, 28'th Mar 2023
ETFs provide stability and diversification to a portfolio.
Better Buy: AbbVie vs. Johnson & Johnson
05:30am, Saturday, 25'th Mar 2023
AbbVie and J&J both are facing big transitions this year. These stocks look inexpensive today, both trading at around 14 times forward earnings estimates.
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
02:28pm, Friday, 24'th Mar 2023
AbbVie???s (ABBV) two studies evaluating Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus meet their primary endpoints.
Final Trades: AbbVie, Nike, FedEx & more
02:26pm, Thursday, 23'rd Mar 2023
The "Halftime Report" traders give their top picks to watch for the second half.
AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate
11:27am, Thursday, 23'rd Mar 2023
In the CRL, the FDA asks AbbVie (ABBV) for some extra information about the pump device used to administer the Parkinson's disease medicine, ABBV-951.
2 Reasons to Buy AbbVie, and 1 Reason to Sell
05:30am, Thursday, 23'rd Mar 2023
AbbVie's top-selling drug is facing competition -- and lower revenue. The company still has much to offer long-term investors.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:44am, Wednesday, 22'nd Mar 2023
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
These 3 Dividend Growers Yield More Than the 10-Year Note
08:46am, Wednesday, 22'nd Mar 2023
Backed by the U.S. government, the closely watched 10-year Treasury note offers a high degree of safety that stocks and other investments can't match. What they no longer offer, however, is a 4% annua
February 2023 Passive Income - Good Times
02:28am, Friday, 17'th Mar 2023
This month was a fantastic month for dividend raises, adding a solid $101.39 to our forward income. While our dividend income is down, the overall passive income continues to increase.
2 Growth Stocks to Buy Before the Bull Market Arrives
08:30am, Thursday, 16'th Mar 2023
AbbVie's business is trading at a discount, and that's a mistake investors should pounce on. Nvidia's stock should continue to rally as PC sales strengthen and companies get back to upgrading IT.
4 Factor Dividend Growth Portfolio - First Insight
03:21am, Thursday, 16'th Mar 2023
The 4-factor dividend growth portfolio was launched on November 1st, 2022, and is performing quite well. The portfolio lost by 34 bps to the S&P 500 Total Return during the month of February.
Marijuana Stocks For Your March 2023 Watchlist
01:43pm, Wednesday, 15'th Mar 2023
Here Are A Few Marijuana Stocks For Your Portfolio The post Marijuana Stocks For Your March 2023 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Indust
AbbVie: Comparing The Current Valuation To Its Last Growth Cycle
12:43pm, Tuesday, 14'th Mar 2023
AbbVie is one of the most prominent biotechnology/healthcare stocks known for paying a good dividend. Besides the dividend, AbbVie didn't generate any returns on a one-year basis and is still a bit aw
Healthcare Stocks With at Least 30 Years of Dividend Increases
11:01am, Tuesday, 14'th Mar 2023
While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of t
